Significant weight gain is a common side effect of many psychiatric medications. Fortunately, there are options for those who ...

and glucagon receptors (GCGR), leading to weight loss through reduced appetite and increased energy expenditure. DA-1726 has a well understood mechanism and, in pre-clinical mice models ...

A Chinese research team has uncovered a previously unknown gut-joint axis mechanism that drives osteoarthritis, ...

The escalating global prevalence of obesity and type 2 diabetes mellitus (T2DM) underscores the urgent need for innovative ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Studies show that GLP-1 agonists can help patients lose 5-15% of their body weight when combined with diet and exercise.

Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

In April 2024, Entera announced that the Journal of Bone and Mineral Research (JBMR) published EB613 placebo controlled Phase 2 Trial results, highlighting its dual mechanism of action and rapid ...

The treatment, called UBT251, activates receptors of three hormones: GLP-1, GIP, and glucagon. This is the same mechanism as Eli Lilly’s next-generation “triple-G” drug retatrutide ...

BEIJING -- A Chinese research team has uncovered a previously unknown "gut-joint axis" mechanism that drives ... intestinal FXR receptor and increasing glucagon-like peptide-1 (GLP-1) production.

BEIJING, April 10 (Xinhua) -- A Chinese research team has uncovered a previously unknown "gut-joint axis" mechanism that drives ... FXR receptor and increasing glucagon-like peptide-1 (GLP-1 ...